Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
US Patent 10729751 Injection paradigm for administration of botulinum toxins
Overview
Structured Data
Issues
Contributors
Activity
Access by API
Access by API
Is a
Patent
Current Assignee
Allergan, Inc.
Date Filed
October 29, 2018
Date of Patent
August 4, 2020
Patent Applicant
Allergan, Inc.
Patent Application Number
16173664
Patent Citations Received
US Patent 11033610 Injection paradigm for administration of botulinum toxins
US Patent 10874722 Suture line administration technique using botulinum toxins
Patent Jurisdiction
United States Patent and Trademark Office
Patent Number
10729751
Patent Primary Examiner
Michelle F. Paguio Frising
Find more entities like US Patent 10729751 Injection paradigm for administration of botulinum toxins
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
SUBSCRIBE